Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mr P Beatty 11/02/2019 Mrs S Beatty 11/02/2019 16 December 2025 The principal activity of the Company during the financial year was that of anaesthesiologist consultancy services. SC620900 2025-03-31 SC620900 bus:Director1 2025-03-31 SC620900 bus:Director2 2025-03-31 SC620900 2024-03-31 SC620900 core:CurrentFinancialInstruments 2025-03-31 SC620900 core:CurrentFinancialInstruments 2024-03-31 SC620900 core:ShareCapital 2025-03-31 SC620900 core:ShareCapital 2024-03-31 SC620900 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC620900 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC620900 core:OtherPropertyPlantEquipment 2024-03-31 SC620900 core:OtherPropertyPlantEquipment 2025-03-31 SC620900 core:CostValuation 2024-03-31 SC620900 core:AdditionsToInvestments 2025-03-31 SC620900 core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 SC620900 core:CostValuation 2025-03-31 SC620900 2023-03-31 SC620900 bus:OrdinaryShareClass1 2025-03-31 SC620900 bus:OrdinaryShareClass2 2025-03-31 SC620900 bus:OrdinaryShareClass3 2025-03-31 SC620900 bus:OrdinaryShareClass4 2025-03-31 SC620900 2024-04-01 2025-03-31 SC620900 bus:FilletedAccounts 2024-04-01 2025-03-31 SC620900 bus:SmallEntities 2024-04-01 2025-03-31 SC620900 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SC620900 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC620900 bus:Director1 2024-04-01 2025-03-31 SC620900 bus:Director2 2024-04-01 2025-03-31 SC620900 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-04-01 2025-03-31 SC620900 2023-04-01 2024-03-31 SC620900 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 SC620900 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 SC620900 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 SC620900 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 SC620900 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 SC620900 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 SC620900 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 SC620900 bus:OrdinaryShareClass4 2024-04-01 2025-03-31 SC620900 bus:OrdinaryShareClass4 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC620900 (Scotland)

ORIEL OCHIL LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

ORIEL OCHIL LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

ORIEL OCHIL LTD

BALANCE SHEET

AS AT 31 MARCH 2025
ORIEL OCHIL LTD

BALANCE SHEET (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 3,184 1,515
Investments 4 54,822 39,564
58,006 41,079
Current assets
Debtors 5 12,113 10,212
Cash at bank and in hand 6 15,515 22,073
27,628 32,285
Creditors: amounts falling due within one year 7 ( 10,927) ( 11,729)
Net current assets 16,701 20,556
Total assets less current liabilities 74,707 61,635
Provision for liabilities 8, 9 0 ( 288)
Net assets 74,707 61,347
Capital and reserves
Called-up share capital 10 80 80
Profit and loss account 74,627 61,267
Total shareholders' funds 74,707 61,347

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Oriel Ochil Ltd (registered number: SC620900) were approved and authorised for issue by the Board of Directors on 16 December 2025. They were signed on its behalf by:

Mr P Beatty
Director
ORIEL OCHIL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
ORIEL OCHIL LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Oriel Ochil Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is C/O Johnston Carmichael Bishop's Court, 29 Albyn Place, Aberdeen, AB10 1YL, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the services provided in the normal course of business.

Turnover is recognised on the accruals basis.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Basic financial assets
Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors are recognised at transaction price.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Provisions

Deferred tax provisions are recognised when the Company has a present obligation as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2024 7,535 7,535
Additions 3,068 3,068
At 31 March 2025 10,603 10,603
Accumulated depreciation
At 01 April 2024 6,020 6,020
Charge for the financial year 1,399 1,399
At 31 March 2025 7,419 7,419
Net book value
At 31 March 2025 3,184 3,184
At 31 March 2024 1,515 1,515

4. Fixed asset investments

Listed investments Total
£ £
Cost or valuation before impairment
At 01 April 2024 39,564 39,564
Additions 19,167 19,167
Movement in fair value ( 3,909) ( 3,909)
At 31 March 2025 54,822 54,822
Carrying value at 31 March 2025 54,822 54,822
Carrying value at 31 March 2024 39,564 39,564

5. Debtors

2025 2024
£ £
Trade debtors 11,230 9,329
Other debtors 883 883
12,113 10,212

6. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 15,515 22,073

7. Creditors: amounts falling due within one year

2025 2024
£ £
Taxation and social security 3,707 4,246
Other creditors 7,220 7,483
10,927 11,729

8. Provision for liabilities

2025 2024
£ £
Deferred tax 0 288

9. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 288) ( 563)
Credited to the Statement of Income and Retained Earnings 288 275
At the end of financial year 0 ( 288)

10. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
50 A ordinary shares of £ 1.00 each 50 50
10 B ordinary shares of £ 1.00 each 10 10
10 C ordinary shares of £ 1.00 each 10 10
10 D ordinary shares of £ 1.00 each 10 10
80 80

11. Related party transactions

Transactions with the entity's directors

2025 2024
£ £
Key Management Personnel 4,521 5,883

The above loan is interest free and there are no fixed terms of repayment.